SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-039790
Filing Date
2019-11-04
Accepted
2019-11-04 16:11:39
Documents
73
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q myok-10q_20190930.htm   iXBRL 10-Q 2697543
2 EX-10.1 myok-ex101_145.htm EX-10.1 367773
3 EX-10.2 myok-ex102_42.htm EX-10.2 100436
4 EX-31.1 myok-ex311_7.htm EX-31.1 15764
5 EX-31.2 myok-ex312_8.htm EX-31.2 15848
6 EX-32.1 myok-ex321_6.htm EX-32.1 8716
  Complete submission text file 0001564590-19-039790.txt   9104394

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA myok-20190930.xsd EX-101.SCH 55861
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE myok-20190930_cal.xml EX-101.CAL 54444
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE myok-20190930_def.xml EX-101.DEF 154015
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE myok-20190930_lab.xml EX-101.LAB 395316
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myok-20190930_pre.xml EX-101.PRE 302116
28 EXTRACTED XBRL INSTANCE DOCUMENT myok-10q_20190930_htm.xml XML 1656303
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37609 | Film No.: 191189911
SIC: 2834 Pharmaceutical Preparations